Compounds > tolbutamide
Page last updated: 2024-11-05

tolbutamide and Retroperitoneal Neoplasms

tolbutamide has been researched along with Retroperitoneal Neoplasms in 2 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Retroperitoneal Neoplasms: New abnormal growth of tissue in the RETROPERITONEAL SPACE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BOSHELL, BR1
KIRSCHENFELD, JJ1
SOTERES, PS1
GINSBERG, DM1

Reviews

1 review available for tolbutamide and Retroperitoneal Neoplasms

ArticleYear
HYPOGLYCEMIA ASSOCIATED WITH EXTRAPANCREATIC NEOPLASMS, WITH A NOTE ON OTHER UNUSUAL FORMS OF HYPOGLYCEMIA.
    Advances in internal medicine, 1964, Volume: 12

    Topics: Adrenogenital Syndrome; Carcinoma, Hepatocellular; Drug Therapy; Glycogen Storage Disease Type I; Hu

1964

Other Studies

1 other study available for tolbutamide and Retroperitoneal Neoplasms

ArticleYear
EXTRAPANCREATIC INSULIN-SECRETING TUMOR.
    The New England journal of medicine, 1964, Feb-13, Volume: 270

    Topics: Fibrosarcoma; Geriatrics; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Leucine; Pathology;

1964